Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
about
Ten putative contributors to the obesity epidemicIdentification and importance of brown adipose tissue in adult humansNeurohumoral stimulation in type-2-diabetes as an emerging disease conceptThe metabolic vascular syndrome - guide to an individualized treatmentAdvances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert ForumDifferential sympathetic outflow to adipose depots is required for visceral fat loss in response to calorie restrictionOctopamine controls starvation resistance, life span and metabolic traits in DrosophilaTreatment of hypertension in obese patients.Effect of cardiometabolic risk factors on hypertension management: a cross-sectional study among 28 physician practices in the United States.A socioecological framework for research on work and obesity in diverse urban transit operators based on gender, race, and ethnicity.Pharmacological and non-pharmacological interventions to influence adipose tissue function.Metabolic syndrome and migraine.Use of beta-blockers in obesity hypertension: potential role of weight gain.Optimizing blood pressure control in the obese patient.Endogenous epinephrine protects against obesity induced insulin resistance.Arterial hypertension and ischaemic stroke.Medical complications of obesity and optimization of the obese patient for colorectal surgery.Preventive treatment of migraine: effect on weight.Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trialMedications associated with weight gain.Drug-induced metabolic syndrome.Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalitiesDiagnosis and management of hypertension in obesity.Obesity cardiomyopathy: diagnosis and therapeutic implications.Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: In vitro and in vivo evidenceManagement of arterial hypertension in obese patients.Antihypertensive medications and their effects on lipid metabolism.Current pharmacotherapeutic concepts for the treatment of obesity in adults.Obesity is a sign - over-eating is a symptom: an aetiological framework for the assessment and management of obesity.Beta-adrenergic antagonists in hypertension: a review of the evidence.Diabesity: therapeutic options.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.β-blockers: a review of their pharmacological and physiological diversity in hypertension.A Review of Potential Marine-derived Hypotensive and Anti-obesity Peptides.Autonomic nervous system dysfunction in obesity and Prader-Willi syndrome: current evidence and implications for future obesity therapies.The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity.Differential Metabolic Effects of Beta-Blockers: an Updated Systematic Review of Nebivolol.Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
P2860
Q24619245-55D52008-D974-4BE0-8CF9-F79C875B296DQ24632425-F40C3358-9E32-4B64-87D8-E3D6CAEF8085Q24798310-31261740-4D86-4B9E-B467-8E9D18E80EEEQ26767142-A4AC3938-8E99-4AE0-AF6A-775AE97B89D1Q26784022-2B16422B-9A47-4A71-88F0-2AE9A4E86E3CQ30252687-C3FB7429-FF7A-4CA9-9B5F-987B61A19DF9Q30355723-68C00553-1F6C-4EA1-9820-E6EB4BF3D6D1Q30429298-FC4820AF-636B-4AFB-A87B-0781A8040AA5Q33669542-6D972DA4-2B31-44FC-A557-353EF99B213DQ33702804-732212D6-7853-48C2-BCB6-2E70D3763239Q34576535-9ACE4E51-B0DA-42CF-B7DC-3B41DF407677Q34645695-0A730F67-33DA-46E2-A832-82AAA7AEB7C5Q34742783-37154898-A105-4050-AE35-8F786343493FQ34824920-0F6DBFD4-B17E-4B3C-9F25-FB61C637E771Q35036906-40B69C6E-D463-4F8C-80D6-A51946894239Q35098824-AF3DF86C-804C-465D-AD72-869AD764B40EQ35850150-ADBA8544-D8D0-46F2-B703-6EBE4B2B7E67Q35987931-70067E2B-7D32-4BB7-A315-888382D0EAD9Q36156527-FCBAE965-3975-4613-8C53-0385DCB7137EQ36309632-E25AD5EA-303D-4698-90CD-999E3E2E2A63Q36392681-0EE4B9A1-41F4-403E-822B-75041FC40FA3Q36400253-D1BE2DB6-E990-4776-9DB4-458953C04AB7Q36455910-7366C671-2FB7-457F-AF5C-9748CCA019D0Q36915912-830DDF0D-39E6-4D81-9DD0-C0AFE4FE79DEQ36986429-F07B81CB-756E-4BDC-82C8-CCC6E9735FE9Q37119330-0F56B23A-0F08-4118-A149-55C0640AAFAEQ37215444-AA6EF29C-CFA4-438D-8CE9-7E63D07B7CCDQ37368688-24173148-BA17-454C-8199-26A8B2604BFBQ37634582-20C6FE1C-CB91-4140-9E16-BF6AE81B5118Q37637751-4C60156C-4F92-42A0-A628-F0356C11033AQ37762294-BE0BA645-2621-4FAA-B18F-96892D25A362Q38071133-D327AC17-3B0E-471B-9945-AD463DE0857DQ38080812-3740B6AB-A9D3-4371-A4DC-9FD401BEE2FDQ38200949-1A0481D7-104F-42D2-BFB7-CB4F79381946Q38311340-6F73CD42-A4FE-4C40-8CB5-F2F912D9C9F4Q38317227-6069D0A8-7B51-4471-A980-C5D06CF2FC7BQ38332289-E1CFF4D1-126C-4574-B765-A148CBFE52D5Q38677949-A23F3558-9D3B-4B21-8C2C-2B8175E291F9Q38913816-C9137C2E-1C1F-4E3F-AE2B-B2B882B88CEDQ39404106-2B536FCF-BB41-4170-84DD-6593D329358D
P2860
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@ast
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@en
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@nl
type
label
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@ast
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@en
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@nl
prefLabel
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@ast
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@en
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@nl
P2093
P356
P1433
P1476
Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis.
@en
P2093
P304
P356
10.1161/01.HYP.37.2.250
P407
P577
2001-02-01T00:00:00Z